Video-Assisted Laser Resection of Lung Metastases-Feasibility of a New Surgical Technique.
Conclusion Video-assisted laser resection of lung metastases is safe, effective, and fulfills the requirements of modern lung metastases surgery. PMID: 28110489 [PubMed - as supplied by publisher]
Giving CDK4/6 inhibitors to breast cancer patients aged ≥ 70 years yields a similar progression-free survival to that seen in younger women, although the toxicity is more severe, say FDA researchers.Medscape Medical News
LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.
CONCLUSIONS: Based on the above results, in-depth measures to continuously increase intake of fruits and vegetables in children and adolescents are needed. This study can be used as basic data for the development of educational programs for dietary improvements. PMID: 29222902 [PubMed - in process]
Abstract BACKGROUND AND OBJECTIVES: The potential benefits of home enteral nutrition (HEN) and the effects of HEN on quality of life (QOL) after esophagectomy remain unclear. The aim was to investigate the effect of 3 months HEN on health related QOL and nutritional status of esophageal cancer patients who were preoperatively malnourished. METHODS AND STUDY DESIGN: 142 malnourished (PG-SGA stage B or C) patients with esophageal cancer were assigned to receive Ivor Lewis minimally invasive esophagectomy (MIE group) with laparoscopic jejunal feeding tube placement or open esophagectomy (OE group) with nasojejun...
CONCLUSIONS: NCDs and their risk factors are emerging problems in Vietnam, which need both disease-specific and sensitive strategies in health and related sectors. PMID: 29222878 [PubMed - in process]
CONCLUSIONS Taken together, REG1A regulates cell invasion, apoptosis and viability in GC through activating PI3K/Akt-GSK3β signaling. REG1A may serve as a promising therapeutic strategy for GC. PMID: 29222406 [PubMed - in process]
All women aged between 50 and 70 are offered screening for breast cancer. But how effective is it at stopping deaths – and might it actually do more harm than good?Many of us will know someone who had breast cancer found at screening. The cancer seen on a mammogram may have been microscopic, so early in its malignant life that it hadn ’t broken through the wall of its milk duct. Thank heavens, then, for breast screening, which is offered to all women between 50 and 70 in the UK and other countries. It is promoted enthusiastically as lifesaving, but does it deliver on its promise? And are the randomised con...
PET/MRI can better detect and classify local lesions and distant metastases...Read more on AuntMinnie.comRelated Reading: ASTRO: PET predicts outcomes in vulvar cancer patients PET/MRI matches PET/CT for recurrent pelvic cancer SNMMI: FDG-PET/CT predicts ovarian cancer survival DWI adds little to PET/MRI for female pelvic malignancies PET/MRI matches PET/CT for gynecological malignancies
ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday
LOS ANGELES (Reuters) - Merck&Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Colorectal Cancer | Heart | Kidney Cancer | Laser Surgery | Melanoma | Oropharyngeal Cancer | Renal Cell Carcinoma | Seminoma | Skin Cancer | Study | Testicular Cancer | Women